BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 105 filers reported holding BIOSCRIP INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coliseum Capital Management, LLC | 5,622,410 | $5,847,000 | 2.64% |
| NORTH TIDE CAPITAL, LLC | 8,500,000 | $8,840,000 | 1.51% |
| WYNNEFIELD CAPITAL INC | 3,700,000 | $3,848,000 | 1.39% |
| Alta Fundamental Advisers LLC | 2,330,774 | $2,424,000 | 1.20% |
| ARDSLEY ADVISORY PARTNERS LP | 6,350,000 | $6,604,000 | 1.09% |
| Camber Capital Management LP | 10,180,000 | $10,587,000 | 0.55% |
| PERKINS CAPITAL MANAGEMENT INC | 298,000 | $310,000 | 0.34% |
| Hawk Ridge Capital Management | 340,429 | $354,000 | 0.18% |
| Eidelman Virant Capital | 220,000 | $228,000 | 0.13% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 227,280 | $236,000 | 0.11% |